Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.
about
Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysisPharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsTowards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value ChangesDramatyping: a generic algorithm for detecting reasonable temporal correlations between drug administration and lab value alterationsLeveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.Potentially inappropriate medication in the elderly in Germany: an economic appraisal of the PRISCUS listIndividualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.Swimming Against the Tide: Primary Care Physicians' Views on Deprescribing in Everyday Practice.Factors Influencing the Frequency of Emergency Department Utilization by Individuals with Substance Use Disorders.Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.Adverse Drug Event Discovery Using Biomedical Literature: A Big Data Neural Network Adventure.Safer Prescribing and Care for the Elderly (SPACE): Protocol of a Cluster Randomized Controlled Trial in Primary Care.The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials.Adverse Drug Reactions (ADR) and Emergencies.In Reply
P2860
Q27335783-15AB9D88-53B4-4F81-93EB-DAC0C1BA4773Q28066096-0EB9262D-66C8-4982-8800-CF2D1FDE2BC2Q28547437-54905891-C4FC-4CEA-814C-65010783460AQ28601745-06720D52-F05D-4CE9-BEC5-B1149BA6EB76Q35765427-328DBF01-DFA4-4D72-9291-EF0A873375C3Q35978059-981D7FD7-0D0B-42AB-A4C6-D9ACAEFB7561Q35998552-E475585C-EBCD-48B8-9C37-0037FF32F78FQ39426802-2E6D9432-2B50-4A68-A9DD-105F177B36B9Q39998419-652B7CB4-EAB0-4B7E-9713-BE053243305BQ41702201-16A0DBAB-4BED-4433-AAE2-FA33721C7CBDQ45943118-C0B8D792-F5F7-45EA-B8DA-8FBF09B755E2Q52560393-24F11D10-C7AF-4D4F-8FF2-7B91E43EE952Q55261032-03AFA0A8-3A6F-436A-9055-9EC4CBC80C10Q55311475-17E3AA2D-8404-4526-AA95-9DC5C21ABBAAQ58694391-3B52105E-441B-4B07-B873-B50F087F4944
P2860
Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Adverse drug events in patient ...... : an analysis of direct costs.
@en
Adverse drug events in patient ...... : an analysis of direct costs.
@nl
type
label
Adverse drug events in patient ...... : an analysis of direct costs.
@en
Adverse drug events in patient ...... : an analysis of direct costs.
@nl
prefLabel
Adverse drug events in patient ...... : an analysis of direct costs.
@en
Adverse drug events in patient ...... : an analysis of direct costs.
@nl
P2093
P2860
P356
P1476
Adverse drug events in patient ...... : an analysis of direct costs.
@en
P2093
Andrius Patapovas
Anja Sonst
Barbara Pfistermeister
Bettina Plank-Kiegele
Fabian Müller
Florian Meier
Harald Dormann
Oliver Schöffski
Renke Maas
Thomas Bürkle
P2860
P304
P356
10.1002/PDS.3663
P577
2014-06-17T00:00:00Z